These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1287187)

  • 1. Enantioselective oral bioavailability of 0-isovaleryl propranolol as a potential prodrug of propranolol.
    Shameem M; Imai T; Otagiri M
    J Pharmacobiodyn; 1992 Sep; 15(9):535-40. PubMed ID: 1287187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol.
    Shameem M; Imai T; Otagiri M
    J Pharm Pharmacol; 1993 Apr; 45(4):246-52. PubMed ID: 8098362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained propranolol delivery and increased oral bioavailability in dogs given a propranolol Laurate salt.
    Aungst BJ; Hussain MA
    Pharm Res; 1992 Nov; 9(11):1507-9. PubMed ID: 1475241
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in human serum.
    Takahashi K; Haginaka J; Tamagawa S; Nishihata T; Yasuda H; Katagi T
    J Pharm Pharmacol; 1990 May; 42(5):356-7. PubMed ID: 1976786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-pass hydrolysis of a propranolol ester derivative in rat small intestine.
    Masaki K; Taketani M; Imai T
    Drug Metab Dispos; 2006 Mar; 34(3):398-404. PubMed ID: 16326813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
    Ahmed S; Imai T; Otagiri M
    Pharm Res; 1996 Oct; 13(10):1524-9. PubMed ID: 8899845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T; Yoshigae Y; Hosokawa M; Chiba K; Otagiri M
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1234-42. PubMed ID: 14534358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver.
    Yoshigae Y; Imai T; Horita A; Otagiri M
    Chirality; 1997; 9(7):661-6. PubMed ID: 9366026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of propranolol following oral and transdermal administration in rabbits.
    Corbo M; Liu JC; Chien YW
    J Pharm Sci; 1990 Jul; 79(7):584-7. PubMed ID: 2398465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
    Egginger G; Lindner W; Brunner G; Stoschitzky K
    J Pharm Biomed Anal; 1994 Dec; 12(12):1537-45. PubMed ID: 7696378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
    Ahmed S; Imai T; Yoshigae Y; Otagiri M
    Life Sci; 1997; 61(19):1879-87. PubMed ID: 9364192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma propranolol levels in beagle dogs after administration of propranolol hemisuccinate ester.
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1978 Oct; 67(10):1360-3. PubMed ID: 702279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
    Ahmed S; Imai T; Otagiri M
    Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacokinetics of propranolol and its conjugated metabolites in patients with chronic ischemic heart disease and arterial hypertension with a one-time and course intake of the drug].
    Belolipetskaia VG; Rumiantsev DS; Piotrovskiĭ VK; Metelitsa VI; Duda SG; Ostrovskaia TP; Kokurina EV; Martseva SIu; Bochkareva EV; Filatova NP
    Eksp Klin Farmakol; 1995; 58(6):56-9. PubMed ID: 8704616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
    Lindner W; Rath M; Stoschitzky K; Semmelrock HJ
    Chirality; 1989; 1(1):10-3. PubMed ID: 2642031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterisation of palymitoyl propanolol hydrochloride auto-lymphotrophs for oral administration.
    Vyas SP; Jaitely V; Kanaujia P
    Int J Pharm; 1999 Sep; 186(2):177-89. PubMed ID: 10486436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.